PC
TVGNW icon

Periscope Capital’s Tevogen Bio Warrant TVGNW Stock Holding History

Periscope Capital’s Portfolio TVGNW Stock Details TVGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100,000
Closed -$5.39K – 254
2025
Q1 		$5.39K Hold
100,000
– – ﹤0.01% 185
2024
Q4 		$5.4K Sell
100,000
-345,900
-78% -$19K ﹤0.01% 170
2024
Q3 		$5.75K Hold
445,900
– – ﹤0.01% 205
2024
Q2 		$8.96K Sell
445,900
-163,000
-27% -$7.66K ﹤0.01% 248
2024
Q1 		$50.2K Sell
608,900
-125,000
-17% -$7.49K 0.01% 223
2023
Q4 		$29.4K Hold
733,900
– – 0.01% 299
2023
Q3 		$36.7K Hold
733,900
– – ﹤0.01% 407
2023
Q2 		$30.3K Buy
733,900
+157,979
+27% +$8.53K ﹤0.01% 503
2023
Q1 		$46.1K Buy
575,921
+176,209
+44% +$9.74K ﹤0.01% 547
2022
Q4 		$2.62K Hold
399,712
– – ﹤0.01% 877
2022
Q3 		$48K Buy
399,712
+27,012
+7% +$3.9K ﹤0.01% 712
2022
Q2 		$60K Hold
372,700
– – ﹤0.01% 673
2022
Q1 		$101K Buy
+372,700
New +$139K ﹤0.01% 758

Other funds holding TVGNW

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Periscope Capital's TVGNW Position: Q2 2025 in Review

Periscope Capital sold out of Tevogen Bio Warrant (TVGNW) in Q2 2025, closing a stake of 100,000 shares — an estimated $5.39K sold.

Periscope Capital first reported a position in TVGNW in Q1 2022 and held it in 13 quarters. The position peaked at $101K in Q1 2022. 37 funds tracked by Wall St. Rank hold TVGNW as of Q2 2025.

  • Periscope Capital reported no remaining Tevogen Bio Warrant position as of Q2 2025 after selling out during the quarter.
  • Periscope Capital sold 100,000 Tevogen Bio Warrant shares in Q2 2025, an estimated $5.39K.
  • Periscope Capital first reported a position in Tevogen Bio Warrant in Q1 2022 and held it in 13 quarters.
  • Periscope Capital's Tevogen Bio Warrant position peaked at $101K in Q1 2022.
  • 37 funds tracked by Wall St. Rank held Tevogen Bio Warrant as of Q2 2025.

Based on Periscope Capital's 13F filing for Q2 2025, filed 14 Aug 2025.